703 related articles for article (PubMed ID: 19361798)
21. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
22. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.
Nafiye Y; Sevtap K; Muammer D; Emre O; Senol K; Leyla M
Fertil Steril; 2010 Apr; 93(6):1864-9. PubMed ID: 19171332
[TBL] [Abstract][Full Text] [Related]
23. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
Nardo LG; Yates AP; Roberts SA; Pemberton P; Laing I
Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605
[TBL] [Abstract][Full Text] [Related]
24. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
[TBL] [Abstract][Full Text] [Related]
25. The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome.
Yilmaz N; Uygur D; Dogan M; Ozgu E; Salman B; Mollamahmutoglu L
Gynecol Endocrinol; 2012 Mar; 28(3):162-5. PubMed ID: 22103791
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the relationship between follicular fluid oxidative stress, ovarian hormones, and response to gonadotropin stimulation.
Appasamy M; Jauniaux E; Serhal P; Al-Qahtani A; Groome NP; Muttukrishna S
Fertil Steril; 2008 Apr; 89(4):912-21. PubMed ID: 17681319
[TBL] [Abstract][Full Text] [Related]
28. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
[TBL] [Abstract][Full Text] [Related]
29. Follicular fluid soluble receptor for advanced glycation end-products (sRAGE): a potential indicator of ovarian reserve.
Merhi Z; Irani M; Doswell AD; Ambroggio J
J Clin Endocrinol Metab; 2014 Feb; 99(2):E226-33. PubMed ID: 24276462
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development.
Wang TH; Chang CL; Wu HM; Chiu YM; Chen CK; Wang HS
Fertil Steril; 2006 Nov; 86(5):1392-401. PubMed ID: 17070193
[TBL] [Abstract][Full Text] [Related]
31. Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
Cupisti S; Dittrich R; Mueller A; Strick R; Stiegler E; Binder H; Beckmann MW; Strissel P
Eur J Med Res; 2007 Dec; 12(12):604-8. PubMed ID: 18024272
[TBL] [Abstract][Full Text] [Related]
32. Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome.
Chen Y; Ye B; Yang X; Zheng J; Lin J; Zhao J
J Int Med Res; 2017 Jun; 45(3):1138-1147. PubMed ID: 28449632
[TBL] [Abstract][Full Text] [Related]
33. [Anti-Mullerian hormone and polycystic ovary syndrome].
Catteau-Jonard S; Dewailly D
Gynecol Obstet Fertil; 2011 Sep; 39(9):514-7. PubMed ID: 21840745
[TBL] [Abstract][Full Text] [Related]
34. Anti-Mullerian hormone (AMH): what do we still need to know?
La Marca A; Broekmans FJ; Volpe A; Fauser BC; Macklon NS;
Hum Reprod; 2009 Sep; 24(9):2264-75. PubMed ID: 19520713
[TBL] [Abstract][Full Text] [Related]
35. Anti-Müllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients.
Sahmay S; Guralp O; Aydogan B; Cepni I; Oral E; Irez T
Gynecol Endocrinol; 2013 May; 29(5):440-3. PubMed ID: 23461296
[TBL] [Abstract][Full Text] [Related]
36. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
[TBL] [Abstract][Full Text] [Related]
37. Anti-Müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization.
Fanchin R; Mendez Lozano DH; Frydman N; Gougeon A; di Clemente N; Frydman R; Taieb J
J Clin Endocrinol Metab; 2007 May; 92(5):1796-802. PubMed ID: 17327387
[TBL] [Abstract][Full Text] [Related]
38. Concentrations of anti-Müllerian hormone in fluid from small human antral follicles show a negative correlation with CYP19 mRNA expression in the corresponding granulosa cells.
Eilsø Nielsen M; Rasmussen IA; Fukuda M; Westergaard LG; Yding Andersen C
Mol Hum Reprod; 2010 Sep; 16(9):637-43. PubMed ID: 20064870
[TBL] [Abstract][Full Text] [Related]
39. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
[TBL] [Abstract][Full Text] [Related]
40. Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone.
Foong SC; Abbott DH; Lesnick TG; Session DR; Walker DL; Dumesic DA
Fertil Steril; 2005 May; 83(5):1377-83. PubMed ID: 15866572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
